Nasdaq Riga decided on May 14, 2015 to apply observation status to AS "Rīgas farmaceitiskā fabrika" (FRM1R, ISIN code: LV0000100782).
Observation status will be applied according to Nasdaq Riga Listing and Disclosure rules Article 20.1.2, Subarticle 7, which stipulates that the Issuer shall be placed on observation status if in the next 6 months it is planned to perform activities in the result of which the financial instruments of the Issuer would be delisted.
On May 14, 2015 AS "Rīgas farmaceitiskā fabrika" published announcement about convocation of company’s extraordinary shareholders meeting to take place on June 16, 2015 with one agenda item – exclusion of company's shares from the regulated market.
The purpose of applying observation status is to alert the market participants.
Nasdaq Baltic
Issuer Services
+371 67212431
www.nasdaqbaltic.com
Nasdaq Baltic is a common name for exchanges, regulated markets, alternative markets First North operated by NASDAQ OMX companies in the Baltic states, i.e. NASDAQ OMX Tallinn AS, NASDAQ OMX Riga AS and AB NASDAQ OMX Vilnius